Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IncoDev is a specialized medical technology and drug delivery company focused on the design and commercialization of innovative healthcare products. Founded by Dr. Robert Gussin, the former Chief Scientific Officer of Johnson & Johnson, the company leverages deep industry expertise to develop advanced delivery systems, particularly in the respiratory space. Their flagship technology is a proprietary dry powder inhaler (DPI) platform designed to optimize the delivery of pulmonary medications for conditions like asthma and COPD. IncoDev operates as a product incubator, managing the entire development process from initial concept and engineering to regulatory strategy and market readiness. The company primarily engages in strategic partnerships and licensing agreements with pharmaceutical firms to integrate its delivery platforms with therapeutic compounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on INCODEV.